» Articles » PMID: 38267631

Metabolic Heterogeneity in Cancer

Overview
Journal Nat Metab
Publisher Springer Nature
Specialty Endocrinology
Date 2024 Jan 24
PMID 38267631
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells rewire their metabolism to survive during cancer progression. In this context, tumour metabolic heterogeneity arises and develops in response to diverse environmental factors. This metabolic heterogeneity contributes to cancer aggressiveness and impacts therapeutic opportunities. In recent years, technical advances allowed direct characterisation of metabolic heterogeneity in tumours. In addition to the metabolic heterogeneity observed in primary tumours, metabolic heterogeneity temporally evolves along with tumour progression. In this Review, we summarize the mechanisms of environment-induced metabolic heterogeneity. In addition, we discuss how cancer metabolism and the key metabolites and enzymes temporally and functionally evolve during the metastatic cascade and treatment.

Citing Articles

Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance.

Suri C, Pande B, Suhasini Sahithi L, Swarnkar S, Khelkar T, Verma H Cancer Drug Resist. 2025; 8:7.

PMID: 40051496 PMC: 11883236. DOI: 10.20517/cdr.2024.164.


Large-scale CRISPRi screens link metabolic stress to glioblastoma chemoresistance.

Li X, Zhang W, Fang Y, Sun T, Chen J, Tian R J Transl Med. 2025; 23(1):289.

PMID: 40050992 PMC: 11887098. DOI: 10.1186/s12967-025-06261-4.


PERK-Olating Through Cancer: A Brew of Cellular Decisions.

Mazzolini L, Touriol C Biomolecules. 2025; 15(2).

PMID: 40001551 PMC: 11852789. DOI: 10.3390/biom15020248.


Metabolic Heterogeneity in Diffuse Large B-Cell Lymphoma Cells Reveals an Innovative Antimetabolic Combination Strategy.

Lordello L, Nuan-Aliman S, Kielbassa-Elkadi K, Montagne A, Kotta K, Martins I Cancers (Basel). 2025; 17(3).

PMID: 39941763 PMC: 11816127. DOI: 10.3390/cancers17030394.


Metabolic interplays between the tumour and the host shape the tumour macroenvironment.

Altea-Manzano P, Decker-Farrell A, Janowitz T, Erez A Nat Rev Cancer. 2025; .

PMID: 39833533 DOI: 10.1038/s41568-024-00786-4.


References
1.
Bergers G, Fendt S . The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021; 21(3):162-180. PMC: 8733955. DOI: 10.1038/s41568-020-00320-2. View

2.
Goveia J, Pircher A, Conradi L, Kalucka J, Lagani V, Dewerchin M . Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities. EMBO Mol Med. 2016; 8(10):1134-1142. PMC: 5048364. DOI: 10.15252/emmm.201606798. View

3.
Rohatgi N, Ghoshdastider U, Baruah P, Kulshrestha T, Skanderup A . A pan-cancer metabolic atlas of the tumor microenvironment. Cell Rep. 2022; 39(6):110800. DOI: 10.1016/j.celrep.2022.110800. View

4.
Garcia-Jimenez C, Goding C . Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming. Cell Metab. 2018; 29(2):254-267. PMC: 6365217. DOI: 10.1016/j.cmet.2018.11.018. View

5.
Burrell R, McGranahan N, Bartek J, Swanton C . The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013; 501(7467):338-45. DOI: 10.1038/nature12625. View